Annual CFI
$46.22 M
+$33.59 M+266.01%
31 December 2023
Summary:
Aclaris Therapeutics annual cash flow from investing activities is currently $46.22 million, with the most recent change of +$33.59 million (+266.01%) on 31 December 2023. During the last 3 years, it has risen by +$213.85 million (+127.57%). ACRS annual CFI is now -56.26% below its all-time high of $105.68 million, reached on 31 December 2019.ACRS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$2.79 M
+$3.47 M+514.69%
30 September 2024
Summary:
Aclaris Therapeutics quarterly cash flow from investing activities is currently $2.79 million, with the most recent change of +$3.47 million (+514.69%) on 30 September 2024. Over the past year, it has dropped by -$4.75 million (-62.98%). ACRS quarterly CFI is now -95.05% below its all-time high of $56.44 million, reached on 31 December 2019.ACRS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$26.50 M
-$29.74 M-52.88%
30 September 2024
Summary:
Aclaris Therapeutics TTM cash flow from investing activities is currently $26.50 million, with the most recent change of -$29.74 million (-52.88%) on 30 September 2024. Over the past year, it has dropped by -$19.72 million (-42.66%). ACRS TTM CFI is now -76.12% below its all-time high of $111.00 million, reached on 31 March 2020.ACRS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRS Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -63.0% | -42.7% |
| 3 y3 years | +127.6% | +130.5% | +115.8% |
| 5 y5 years | -56.3% | -95.0% | -74.9% |
ACRS Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +127.6% | -91.4% | +113.2% | -52.9% | +115.8% |
| 5 y | 5 years | -56.3% | +127.6% | -95.0% | +103.7% | -76.1% | +115.8% |
| alltime | all time | -56.3% | +127.6% | -95.0% | +103.6% | -76.1% | +115.8% |
Aclaris Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.79 M(-514.7%) | $26.50 M(-52.9%) |
| June 2024 | - | -$674.00 K(-104.0%) | $56.24 M(+51.0%) |
| Mar 2024 | - | $16.83 M(+123.0%) | $37.26 M(-19.4%) |
| Dec 2023 | $46.22 M(+266.0%) | $7.55 M(-76.8%) | $46.22 M(+11.7%) |
| Sept 2023 | - | $32.53 M(-265.5%) | $41.37 M(+311.5%) |
| June 2023 | - | -$19.66 M(-176.2%) | $10.05 M(+18.4%) |
| Mar 2023 | - | $25.80 M(+854.8%) | $8.49 M(-32.7%) |
| Dec 2022 | $12.63 M(-107.5%) | $2.70 M(+122.0%) | $12.63 M(+1583.7%) |
| Sept 2022 | - | $1.22 M(-105.7%) | $750.00 K(-102.0%) |
| June 2022 | - | -$21.22 M(-170.9%) | -$38.14 M(-38.9%) |
| Mar 2022 | - | $29.93 M(-426.2%) | -$62.39 M(-62.8%) |
| Dec 2021 | -$167.63 M(-2724.6%) | -$9.18 M(-75.6%) | -$167.63 M(+4.3%) |
| Sept 2021 | - | -$37.67 M(-17.1%) | -$160.76 M(+36.4%) |
| June 2021 | - | -$45.47 M(-39.6%) | -$117.85 M(+42.2%) |
| Mar 2021 | - | -$75.31 M(+3167.4%) | -$82.87 M(-1397.5%) |
| Dec 2020 | $6.39 M(-94.0%) | -$2.31 M(-144.0%) | $6.39 M(-90.2%) |
| Sept 2020 | - | $5.24 M(-149.9%) | $65.13 M(-20.2%) |
| June 2020 | - | -$10.49 M(-175.2%) | $81.57 M(-26.5%) |
| Mar 2020 | - | $13.94 M(-75.3%) | $111.00 M(+5.0%) |
| Dec 2019 | $105.68 M | $56.44 M(+160.4%) | $105.68 M(-597.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $21.67 M(+14.4%) | -$21.27 M(-34.7%) |
| June 2019 | - | $18.95 M(+120.0%) | -$32.54 M(-14.8%) |
| Mar 2019 | - | $8.62 M(-112.2%) | -$38.21 M(-507.9%) |
| Dec 2018 | $9.37 M(-116.8%) | -$70.51 M(-778.3%) | $9.37 M(-83.9%) |
| Sept 2018 | - | $10.39 M(-21.8%) | $58.31 M(+623.7%) |
| June 2018 | - | $13.29 M(-76.4%) | $8.06 M(-247.7%) |
| Mar 2018 | - | $56.19 M(-360.6%) | -$5.46 M(-90.2%) |
| Dec 2017 | -$55.69 M(-10.0%) | -$21.57 M(-45.9%) | -$55.69 M(-50.3%) |
| Sept 2017 | - | -$39.86 M(>+9900.0%) | -$111.94 M(+46.9%) |
| June 2017 | - | -$226.00 K(-103.8%) | -$76.22 M(+15.3%) |
| Mar 2017 | - | $5.96 M(-107.7%) | -$66.12 M(+6.8%) |
| Dec 2016 | -$61.90 M(-19.6%) | -$77.82 M(+1785.6%) | -$61.90 M(+15.5%) |
| Sept 2016 | - | -$4.13 M(-141.8%) | -$53.57 M(-14.4%) |
| June 2016 | - | $9.87 M(-3.0%) | -$62.56 M(-7.3%) |
| Mar 2016 | - | $10.17 M(-114.6%) | -$67.52 M(-12.3%) |
| Dec 2015 | -$76.95 M(+4225.5%) | -$69.49 M(+429.7%) | -$76.95 M(+931.1%) |
| Sept 2015 | - | -$13.12 M(-367.2%) | -$7.46 M(-232.0%) |
| June 2015 | - | $4.91 M(+559.1%) | $5.66 M(+659.1%) |
| Mar 2015 | - | $745.00 K | $745.00 K |
| Dec 2014 | -$1.78 M(-60.8%) | - | - |
| Dec 2013 | -$4.54 M | - | - |
FAQ
- What is Aclaris Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly CFI year-on-year change?
- What is Aclaris Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Aclaris Therapeutics?
- What is Aclaris Therapeutics TTM CFI year-on-year change?
What is Aclaris Therapeutics annual cash flow from investing activities?
The current annual CFI of ACRS is $46.22 M
What is the all time high annual CFI for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual cash flow from investing activities is $105.68 M
What is Aclaris Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ACRS is $2.79 M
What is the all time high quarterly CFI for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly cash flow from investing activities is $56.44 M
What is Aclaris Therapeutics quarterly CFI year-on-year change?
Over the past year, ACRS quarterly cash flow from investing activities has changed by -$4.75 M (-62.98%)
What is Aclaris Therapeutics TTM cash flow from investing activities?
The current TTM CFI of ACRS is $26.50 M
What is the all time high TTM CFI for Aclaris Therapeutics?
Aclaris Therapeutics all-time high TTM cash flow from investing activities is $111.00 M
What is Aclaris Therapeutics TTM CFI year-on-year change?
Over the past year, ACRS TTM cash flow from investing activities has changed by -$19.72 M (-42.66%)